Study: Safety and Efficacy of the Xanomeline Transdermal Therapeutic System (TTS) in Patients with Mild to Moderate Alzheimers Disease.
Phase II
· Site: 716 (USA) (Dr. Ito)
· consented 2012-10-08
Adverse events
5
Serious AEs
0
Open data queries
0
Luna dropout signal
–
Adverse events
moderate
assessed
2026-08-18
Moderate BLISTER — outcome: NOT RECOVERED/NOT RESOLVED; onset 2012-12-03 (study day 57.0); relationship: POSSIBLE
mild
assessed
2026-08-18
Mild HYPERSENSITIVITY — outcome: NOT RECOVERED/NOT RESOLVED; onset 2013-03-10 (study day 154.0); relationship: NONE
mild
assessed
2026-08-18
Mild HYPERSENSITIVITY — outcome: RECOVERED/RESOLVED; onset 2013-03-10 (study day 154.0); relationship: NONE
moderate
assessed
2026-08-18
Moderate PRURITUS — outcome: NOT RECOVERED/NOT RESOLVED; onset 2012-11-17 (study day 41.0); relationship: NONE
moderate
assessed
2026-08-18
Moderate SWELLING — outcome: NOT RECOVERED/NOT RESOLVED; onset 2012-11-17 (study day 41.0); relationship: NONE
Data queries
No data queries.
☾ Luna engagement
This participant doesn't use Luna.